Tumor Necrosis Factor Alpha Stimulates Killing of Mycobacterium Tuberculosis by Human Neutrophils

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2002 Jul 16

PMID 12117972

Citations 52

Authors

Kevin O Kisich

Michael Higgins

Gill Diamond

Leonid Heifets

Affiliations

Soon will be listed here.

Abstract

The ability of human neutrophils to aid in defense against pulmonary infection with Mycobacterium tuberculosis is controversial. In this study, we have shown that neutrophils respond to and phagocytose M. tuberculosis in human lesions. Neutrophils from healthy individuals were able to kill significant fractions of an inoculum of M. tuberculosis within 1 h of phagocytosis, and this ability was enhanced by tumor necrosis factor alpha but not by gamma interferon. The mycobactericidal mechanism was nonoxidative, as inhibitors of reactive oxygen or reactive nitrogen intermediates did not interfere with killing. However, the mycobactericidal mechanism was associated with increased exposure of intracellular M. tuberculosis to neutrophil defensins. In vitro, human neutrophil peptides 1 to 3 were not able to kill the bacilli even at much higher levels. These studies support the concept that human neutrophils are directly involved in defense against infection with M. tuberculosis.

Citing Articles

Type I IFN-mediated NET release promotes Mycobacterium tuberculosis replication and is associated with granuloma caseation.

Sur Chowdhury C, Kinsella R, McNehlan M, Naik S, Lane D, Talukdar P Cell Host Microbe. 2024; 32(12):2092-2111.e7.

PMID: 39637864 PMC: 11637906. DOI: 10.1016/j.chom.2024.11.008.

A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy.

Krishnan N, Priestman M, Uhia I, Charitakis N, Glegola-Madejska I, Baer T PLoS Biol. 2024; 22(8):e3002766.

PMID: 39159267 PMC: 11361749. DOI: 10.1371/journal.pbio.3002766.

Neutrophil extracellular trap formation and gene programs distinguish TST/IGRA sensitization outcomes among Mycobacterium tuberculosis exposed persons living with HIV.

Kroon E, Correa-Macedo W, Evans R, Seeger A, Engelbrecht L, Kriel J PLoS Genet. 2023; 19(8):e1010888.

PMID: 37616312 PMC: 10470897. DOI: 10.1371/journal.pgen.1010888.

Role of phagocyte extracellular traps during infections and tuberculosis disease processes.

Garcia-Bengoa M, Meurer M, Goethe R, Singh M, Reljic R, von Kockritz-Blickwede M Front Microbiol. 2023; 14:983299.

PMID: 37492257 PMC: 10365110. DOI: 10.3389/fmicb.2023.983299.

Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.

Kayongo A, Nyiro B, Siddharthan T, Kirenga B, Checkley W, Joloba M Front Cell Infect Microbiol. 2023; 13:1146571.

PMID: 37415827 PMC: 10320222. DOI: 10.3389/fcimb.2023.1146571.

References

Kisich K, Heifets L, Higgins M, Diamond G . Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun. 2001; 69(4):2692-9. PMC: 98208. DOI: 10.1128/IAI.69.4.2692-2699.2001. View

Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, Zaidenstein R . L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation. 2000; 101(12):1358-61. DOI: 10.1161/01.cir.101.12.1358. View

Odeberg H, Olsson I . Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest. 1975; 56(5):1118-24. PMC: 301973. DOI: 10.1172/JCI108186. View

Lehrer R, Szklarek D, Ganz T, Selsted M . Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun. 1985; 49(1):207-11. PMC: 262080. DOI: 10.1128/iai.49.1.207-211.1985. View

Douvas G, Looker D, VATTER A, Crowle A . Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun. 1985; 50(1):1-8. PMC: 262123. DOI: 10.1128/iai.50.1.1-8.1985. View

Ganz T, Selsted M, Szklarek D, Harwig S, Daher K, BAINTON D . Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985; 76(4):1427-35. PMC: 424093. DOI: 10.1172/JCI112120. View

Cross A, Jones O . The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J. 1986; 237(1):111-6. PMC: 1146954. DOI: 10.1042/bj2370111. View

May M, Spagnuolo P . Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect Immun. 1987; 55(9):2304-7. PMC: 260697. DOI: 10.1128/iai.55.9.2304-2307.1987. View

Brown A, Holzer T, Andersen B . Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis. 1987; 156(6):985-9. DOI: 10.1093/infdis/156.6.985. View

10.

Gabay J, Scott R, Campanelli D, Griffith J, Wilde C, Marra M . Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1989; 86(14):5610-4. PMC: 297672. DOI: 10.1073/pnas.86.14.5610. View

11.

Jones G, Amirault H, Andersen B . Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis. 1990; 162(3):700-4. DOI: 10.1093/infdis/162.3.700. View

12.

Denis M . Human neutrophils, activated with cytokines or not, do not kill virulent Mycobacterium tuberculosis. J Infect Dis. 1991; 163(4):919-20. DOI: 10.1093/infdis/163.4.919. View

13.

Denis M . Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 1991; 132(1):150-7. DOI: 10.1016/0008-8749(91)90014-3. View

14.

Hagen F, Grant F, Kuijper J, Slaughter C, Moomaw C, Orth K . Expression and characterization of recombinant human acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides. Biochemistry. 1991; 30(34):8415-23. DOI: 10.1021/bi00098a020. View

15.

Miles A, Owens M, Milligan S, Johnson G, Fields J, Ing T . Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes. J Leukoc Biol. 1995; 58(5):616-22. DOI: 10.1002/jlb.58.5.616. View

16.

Miyakawa Y, Ratnakar P, Rao A, Costello M, Mathieu-Costello O, Lehrer R . In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun. 1996; 64(3):926-32. PMC: 173858. DOI: 10.1128/iai.64.3.926-932.1996. View

17.

Scalettar B, Swedlow J, Sedat J, Agard D . Dispersion, aberration and deconvolution in multi-wavelength fluorescence images. J Microsc. 1996; 182(Pt 1):50-60. DOI: 10.1046/j.1365-2818.1996.122402.x. View

18.

Soong L, Ganz T, Ellison A, Caughey G . Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res. 1997; 46(3):98-102. DOI: 10.1007/s000110050114. View

19.

Travis S, Anderson N, Forsyth W, Espiritu C, Conway B, Greenberg E . Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun. 2000; 68(5):2748-55. PMC: 97484. DOI: 10.1128/IAI.68.5.2748-2755.2000. View

20.

Sharma S, Verma I, Khuller G . Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study. Eur Respir J. 2000; 16(1):112-7. DOI: 10.1034/j.1399-3003.2000.16a20.x. View